Eagles might have an issue on their arms with key participant’s contract

The Philadelphia Eagles simply gained the Tremendous Bowl just a few years in the past, however that looks like an eternity in Philly. This staff, spearheaded by quarterback Jalen Hurts, is completely decided to get again to the large sport as quickly as attainable.

One of the crucial vital positions within the NFL is the edge-rusher. It is easy to inform simply by these guys’ contracts. Edge-rushers are the second-highest-paid place within the league, subsequent to quarterbacks.

However the Eagles could also be paying an excessive amount of for one edge-rusher on their roster. Now, it is coming again to chunk them within the type of some criticism.

Philadelphia Eagles’ Jonathan Greenard is being known as an overpaid star

In a function out on Wednesday, Garrett Podell of CBS Sports activities says that the Eagles have one of the crucial overpaid edge-rushers within the league in Jonathan Greenard. His contract is 4 years, $98 million, with $50 million in new ensures.

The Eagles made a giant funding within the Professional Bowler, buying and selling two third-round picks to the Minnesota Vikings earlier than signing him to his present deal, however that funding is already elevating some issues. Greenard had greater than 12 sacks in each 2023 and 2024, however his sack complete fell to simply three in 12 video games final season. He additionally ended the season with shoulder surgical procedure.

He additionally hasn’t practiced but with the Eagles after being on the PUP checklist with a pectoral pressure suffered whereas weightlifting.

“Philadelphia is banking on a return to well being and that 2025 quarterback strain price as indicators of issues to come back for the 29-year-old, however the wait remains to be on to see him at Eagles coaching camp,” Podell notes. “Defensive coordinator Vic Fangio advised reporters he’ll miss ‘a superb little bit of camp.’ It is also unsure if he’ll even be prepared for Week 1.”

Greenard did submit a career-high 18.1% strain price in 2025 and had his moments, however that does not masks the issues.